Health Care/Hospital
China Life Singapore Provides Complimentary "COVID-19 Vaccine Protection" Coverage to Customers
SINGAPORE, March 26, 2021 /PRNewswire/ -- In view of the current situation of COVID-19 pandemic development, China Life Singapore is committed to taking care of its customers[1] by offering a "COVID-19 Vaccine Protection" coverage. The promotion period is valid from 23 March 2021 to 30 June 2021....
2021-03-26 14:06
2745
Ascentage Pharma Announces Publication of Preclinical Data in Nature Immunology Showing Enhanced T-Cell-Mediated Antitumor Immunity Induced by Its MDM2-p53 Inhibitor APG-115
SUZHOU, China and ROCKVILLE, Md., March 26, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced the peer-reviewed publicati...
2021-03-26 08:38
3164
Antengene Announces Financial Results for Full Year 2020
SHANGHAI and HONG KONG, March 26, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" or "the company", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in h...
2021-03-26 08:00
4379
Chime Biologics Announced the Completion of US$190 Million Series A+ Financing to Accelerate Capacity Expansion
WUHAN, China, March 26, 2021 /PRNewswire/ -- Chime Biologics, a China-based, world-class CDMO company, announced today that it has secured a total commitment ofUS$190 million investment from institutional investors, and over $100 million investment has already been closed today. This round of fin...
2021-03-26 08:00
5766
Amplicore, Inc. Announces Closing of a Successful $4M Seed Funding Round
CINCINNATI, March 26, 2021 /PRNewswire/ -- Amplicore Inc., an early-stage biopharmaceutical company currently developing locally delivered and minimally invasive therapeutic solutions for musculoskeletal diseases, has successfully closed its Series Seed round of funding at$4 million. Investments ...
2021-03-26 05:19
3556
Antengene Appoints Kevin Lynch as Chief Medical Officer
SHANGHAI, China and MELBOURNE, Australia, March 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in ...
2021-03-25 23:26
4449
Antengene Appoints Bo Shan as Chief Scientific Officer
SHANGHAI, March 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, announc...
2021-03-25 22:36
5859
CStone Pharmaceuticals Reports Financial Results and Business Highlights for Full-year 2020
SUZHOU, China, March 25, 2021 /PRNewswire/ -- CStone Pharmaceuticals (CStone, HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology therapies and precision medicines, today reported financial results and business highlights for the f...
2021-03-25 22:03
5000
The New Trace-Temp1 Uses Artificial Intelligence For Non-Contact Temperature Monitoring
SINGAPORE, March 25, 2021 /PRNewswire/ -- T-SMART Pte Ltd has launched an Indiegogo crowdfunding campaign on1 March 2021 to raise fund for the mass production of Trace-Temp1. Trace-Temp1 and its bundled Trace-TempAI mobile application are powered by both artificial intelligence and infrared techn...
2021-03-25 21:20
1796
SOPHiA GENETICS and Hitachi Announce Collaboration to Advance Data Driven Precision Medicine
Multi-year agreement to expand commercial footprint with world-leading genomics platform and develop R&D to unlock the potential of multimodal health data BOSTON, LAUSANNE, Switzerland and TOKYO, March 25, 2021 /PRNewswire/ -- SOPHiA GENETICS SA ("SOPHiA GENETICS"), pioneer in Data-Driven Medicin...
2021-03-25 21:00
5405
Össur Recognized by World Intellectual Property Organization (WIPO) as Leading Assistive Technology Development
REYKJAVIK, Iceland, March 25, 2021 /PRNewswire/ -- Össur (Nasdaq: OSSR), a global leader in the orthotics and prosthetics (O&P) industry with a rich history of ground-breaking innovations, has been recognized by the World Intellectual Property Organization (WIPO) for its intellectual property le...
2021-03-25 20:55
2161
China Life Insurance Company Limited Announces 2020 Annual Results (H Shares)
HONG KONG, March 25, 2021 /PRNewswire/ -- China Life Insurance Company Limited (SSE: 601628, SEHK: 2628, NYSE: LFC) announces the audited consolidated results of the Company (China Life Insurance Company Limited and its subsidiaries) for the year ended31 December 2020 (the "Reporting Period") pre...
2021-03-25 19:29
7055
China Eastern Flies Vaccines to Dominican Republic
SHANGHAI, March 25, 2021 /PRNewswire/ -- A new batch of vaccines developed by
Chinese pharmaceutical companies Sinopharm and Sinovac was delivered onMarch 18
by China Eastern Airlines fromBeijing to the Dominican Republic, according to
theShanghai-based airline.
2021-03-25 19:22
2075
BioNTech Chairman Helmut Jeggle joins the Board of IQM Quantum Computers
MUNICH, March 25, 2021 /PRNewswire/ -- IQM Quantum Computers
2021-03-25 18:29
3449
111 Signs Strategic Cooperation Agreement with Jianming Pharmaceutical to Develop Chronic Disease Management Platform
SHANGHAI, March 25, 2021 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (Nasdaq: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, and Jianming Pharmaceutical Group ("Jianming Pharmaceutical"), a p...
2021-03-25 17:00
2746
AllianThera Biopharma comes out of stealth and collaborates on AI with Insilico Medicine
AllianThera Biopharma led by ex-pharma veterans, Dr. Yuan-Hua Ding and Dr. Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases SUZHOU, China, March 25, 2021 /PRNewswire/ -- Today, AllianThera Biopharma (ATB), a Suzhou,...
2021-03-25 17:00
3424
GenScript Signs a Strategic Partnership with the Theragen Etex and MedPACTO for Therapeutic Antibody Drug development
SINGAPORE, March 25, 2021 /PRNewswire/ -- A global leading biotech company GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) announced that the Company has entered into a strategic partnership with the Theragen Etex, a South Korea-based comprehensive pharmaceutical and biotechnology...
2021-03-25 16:35
4821
Nippon Express Obtains IATA CEIV Pharma Certification for Temperature-controlled Facility near Narita Airport
TOKYO, March 25, 2021 /PRNewswire/ -- Nippon Express Co., Ltd. has obtained IATA CEIV Pharma (*) pharmaceutical transport quality certification for its Narita Temperature-Controlled Hub (NTCH) and for transport operations between NTCH and Narita Airport, effectiveMarch 15. This is the second pha...
2021-03-25 15:00
2888
No COVID slump as majority of Australians satisfied with healthcare system new Australian Healthcare Index reports
MELBOURNE and PERTH, Australia, March 25, 2021 /PRNewswire/ -- Despite a once-in-a-century pandemic still lingering one year on, Australians have given a vote of confidence to the Australian healthcare system with 65.5% rating it a score of 8 or above out of 10 in a new report, produced by the Au...
2021-03-25 03:00
2234
Positive Phase III Clinical Results for EirGenix's Proposed Trastuzumab Biosimilar
TAIPEI, March 24, 2021 /PRNewswire/ -- In a press conference today, EirGenix, Inc. (6589.TT) announced that the Phase III clinical trial (Trial No.: EGC002, NCT03433313) of its breast cancer biosimilar, EG12014 (proposed trastuzumab biosimilar, also called EGI014), has met its primary endpoint. E...
2021-03-24 23:27
4758
Week's Top Stories
Most Reposted
iQIYI LAND Yangzhou to Open on February 8, Marking New Chapter in China's Immersive Entertainment Scene
[Picked up by 273 media titles]
2026-01-01 10:00
Vietnam's Newest EDM Destination, APLUS SAIGON, Debuts With Star-Studded Soft Opening Weekends Featuring Dombresky and Argy
[Picked up by 273 media titles]
2025-12-30 20:12
ACEN completes transition to 100% renewable energy
[Picked up by 273 media titles]
2025-12-29 18:53CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 263 media titles]
2025-12-29 09:00
ChinaAMC launches Depository Receipts of two Chinese flagship ETFs in Thai exchange
[Picked up by 260 media titles]
2025-12-29 14:27